Nicotine Replacement Therapy Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health services
CONCLUSION: The Quitlink intervention did not result in significantly higher rates of prolonged abstinence at 8 months post baseline. However, engagement rates and satisfaction with the 'Quitlink' intervention were high. While underpowered, the Quitlink intervention shows promise. A powered trial to determine its effectiveness for improving long-term cessation is warranted.PMID:37353970 | DOI:10.1177/00048674231181039 (Source: Cancer Control)
Source: Cancer Control - June 24, 2023 Category: Cancer & Oncology Authors: Amanda L Baker Kristen McCarter Alyna Turner Catherine Segan David Castle Lisa Brophy Ron Borland Peter J Kelly Billie Bonevski Donita Baird Sacha Filia John Attia Stuart Szwec Kerrin Palazzi Sarah L White Jill M Williams Anna L Wrobel Andrew Ireland Kari Source Type: research

'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health services
CONCLUSION: The Quitlink intervention did not result in significantly higher rates of prolonged abstinence at 8 months post baseline. However, engagement rates and satisfaction with the 'Quitlink' intervention were high. While underpowered, the Quitlink intervention shows promise. A powered trial to determine its effectiveness for improving long-term cessation is warranted.PMID:37353970 | DOI:10.1177/00048674231181039 (Source: The Australian and New Zealand Journal of Psychiatry)
Source: The Australian and New Zealand Journal of Psychiatry - June 24, 2023 Category: Psychiatry Authors: Amanda L Baker Kristen McCarter Alyna Turner Catherine Segan David Castle Lisa Brophy Ron Borland Peter J Kelly Billie Bonevski Donita Baird Sacha Filia John Attia Stuart Szwec Kerrin Palazzi Sarah L White Jill M Williams Anna L Wrobel Andrew Ireland Kari Source Type: research

The Effects of Scheduled Smoking Reduction and Precessation Nicotine Replacement Therapy on Smoking Cessation: Randomized Controlled Trial With Compliance
CONCLUSIONS: Scheduled smoking, when combined with precessation use of NRT, can result in significantly higher abstinence rates than usual care (abrupt quitting with NRT), particularly in the early postquit phase (2 and 4 weeks after cessation) when smokers are compliant with the procedure. Scheduled smoking also produced a better overall quitting experience by reducing symptoms of nicotine withdrawal and craving, in comparison with usual care, which could encourage future quit attempts. Studies in this area should focus on the use of counseling or other methods to improve adherence.PMID:37338956 | DOI:10.2196/39487 (Source: Cancer Control)
Source: Cancer Control - June 20, 2023 Category: Cancer & Oncology Authors: Paul M Cinciripini Jennifer A Minnix Jason D Robinson George Kypriotakis Yong Cui Janice A Blalock Cho Y Lam David W Wetter Source Type: research

Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders
Conclusion Smokers with MHDs are not sufficiently represented in RCTs examining the safety and effectiveness of smoking cessation medications. Greater access to clinical trial participation needs to be facilitated for this group to better address access to appropriate pharmacotherapeutic interventions in this vulnerable population. (Source: Tobacco Control)
Source: Tobacco Control - June 20, 2023 Category: Respiratory Medicine Authors: Talukder, S. R., Lappin, J. M., Boland, V., McRobbie, H., Courtney, R. J. Tags: Open access Review Source Type: research

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation
CONCLUSIONS: There is high-certainty evidence that using combination NRT versus single-form NRT and 4 mg versus 2 mg nicotine gum can result in an increase in the chances of successfully stopping smoking. Due to imprecision, evidence was of moderate certainty for patch dose comparisons. There is some indication that the lower-dose nicotine patches and gum may be less effective than higher-dose products. Using a fast-acting form of NRT, such as gum or lozenge, resulted in similar quit rates to nicotine patches. There is moderate-certainty evidence that using NRT before quitting may improve quit rates versus using it from qu...
Source: Cancer Control - June 19, 2023 Category: Cancer & Oncology Authors: Annika Theodoulou Samantha C Chepkin Weiyu Ye Thomas R Fanshawe Chris Bullen Jamie Hartmann-Boyce Jonathan Livingstone-Banks Anisa Hajizadeh Nicola Lindson Source Type: research

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation
CONCLUSIONS: There is high-certainty evidence that using combination NRT versus single-form NRT and 4 mg versus 2 mg nicotine gum can result in an increase in the chances of successfully stopping smoking. Due to imprecision, evidence was of moderate certainty for patch dose comparisons. There is some indication that the lower-dose nicotine patches and gum may be less effective than higher-dose products. Using a fast-acting form of NRT, such as gum or lozenge, resulted in similar quit rates to nicotine patches. There is moderate-certainty evidence that using NRT before quitting may improve quit rates versus using it from qu...
Source: Cochrane Database of Systematic Reviews - June 19, 2023 Category: General Medicine Authors: Annika Theodoulou Samantha C Chepkin Weiyu Ye Thomas R Fanshawe Chris Bullen Jamie Hartmann-Boyce Jonathan Livingstone-Banks Anisa Hajizadeh Nicola Lindson Source Type: research

Antenatal interventions to address harmful behaviors and psychosocial risk factors in the prevention of low birth weight
CONCLUSIONS: Professionally provided psychosocial support during pregnancy in general and specifically as a means to reduce smoking can potentially contribute to improved newborn health. The gaps in the investments for research and implementation of psychosocial interventions should be addressed to better meet the global targets in LBW reduction.PMID:37331761 | DOI:10.1016/j.ajcnut.2022.11.028 (Source: The American Journal of Clinical Nutrition)
Source: The American Journal of Clinical Nutrition - June 18, 2023 Category: Nutrition Authors: Annariina M Koivu Pieta K N äsänen-Gilmore Patricia J Hunter Yvonne Muthiani Jaana Isoj ärvi Otto Heimonen Kalpana Bastola Leon Csonka Per Ashorn Ulla Ashorn Source Type: research

Antenatal interventions to address harmful behaviors and psychosocial risk factors in the prevention of low birth weight
CONCLUSIONS: Professionally provided psychosocial support during pregnancy in general and specifically as a means to reduce smoking can potentially contribute to improved newborn health. The gaps in the investments for research and implementation of psychosocial interventions should be addressed to better meet the global targets in LBW reduction.PMID:37331761 | DOI:10.1016/j.ajcnut.2022.11.028 (Source: Am J Clin Nutr)
Source: Am J Clin Nutr - June 18, 2023 Category: Nutrition Authors: Annariina M Koivu Pieta K N äsänen-Gilmore Patricia J Hunter Yvonne Muthiani Jaana Isoj ärvi Otto Heimonen Kalpana Bastola Leon Csonka Per Ashorn Ulla Ashorn Source Type: research

Comparative effect of varenicline and nicotine patches on preventing repeat cardiovascular events
Conclusion We found no difference between varenicline and prescription NRT patches in the risk of recurrent MACE. These results should be considered when determining the most appropriate choice of smoking cessation pharmacotherapy. (Source: Heart)
Source: Heart - June 14, 2023 Category: Cardiology Authors: Robijn, A. L., Filion, K. B., Woodward, M., Hsu, B., Chow, C. K., Pearson, S.-A., Jorm, L., Falster, M. O., Havard, A. Tags: Cardiac risk factors and prevention Source Type: research

Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial
This report describes the design of a double-blind, placebo-controlled, randomised clinical trial that evaluates the effects of the GLP-1RA exenatide as an adjunct to nicotine patches on smoking abstinence and PCWG. Methods and analysis The study will be conducted at two university-affiliated research sites in Houston, Texas, the UTHealth Center for Neurobehavioral Research on Addiction and Baylor College of Medicine Michael E. DeBakey VA Medical Centre. The sample will consist of 216 treatment-seeking smokers with pre-diabetes (haemoglobin A1c of 5.7%–6.4%) and/or overweight (body mass index of 25 kg/m2 or above). ...
Source: BMJ Open - June 14, 2023 Category: General Medicine Authors: Yammine, L., Verrico, C. D., Versace, F., Webber, H. E., Suchting, R., Weaver, M. F., Kosten, T. R., Alibhai, H., Cinciripini, P. M., Lane, S. D., Schmitz, J. M. Tags: Open access, Smoking and tobacco Source Type: research